Discount sale is live
Logo
Angioedema Treatment Market
  2. / Market Insights
  3. Table of Content - Angioedema Treatment Market Analysis
all report title image

Angioedema Treatment Market, By Treatment Type (Plasma-Derived C1-Inhibitors, Recombinant C1-Inhibitors, Kallikrein Inhibitors, Bradykinin B2 Receptor Antagonists, Others), By Disease Type (Hereditary Angioedema, Acquired Angioedema, Idiopathic Angioedema, Others), By Route of Administration (Intravenous, Subcutaneous, Oral, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Oct 2025
  • Code : CMI1371
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
    • 역사적 범위: 2020 - 2024
    • 예측 기간: 2025 - 2032
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Treatment Type

      • Market Snapshot, By Disease Type

      • Market Snapshot, By Route of Administration

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaborations

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Angioedema Treatment Market By Treatment Type, 2025–2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Plasma-Derived C1-Inhibitors

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Recombinant C1-Inhibitors

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Kallikrein Inhibitors

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Bradykinin B2 Receptor Antagonists

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  5. Angioedema Treatment Market By Disease Type, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Hereditary Angioedema

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Acquired Angioedema

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Idiopathic Angioedema

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  6. Angioedema Treatment Market By Route of Administration, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Intravenous

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Subcutaneous

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Oral

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  7. Angioedema Treatment Market By Region, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, For Regions, 2021–2032

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o Middle East & Africa

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • UAE

    • Israel

    • South Africa

    • North Africa

    • Central Africa

    • Rest of Middle East

  1. Competitive Landscape

    • Shire Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • CSL Behring

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Takeda Pharmaceutical Company

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • BioCryst Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • KalVista Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Pharming Group N.V.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Octapharma AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • HAE Pharma

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Sobi

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Novartis

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Idorsia Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Argenx NV

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.